Skip to main content
Premium Trial:

Request an Annual Quote

What's It Worth?

Open Access News links to two articles that take different sides on the question of whether the open access movement is anti-publishing. At Scholarly Kitchen, Kent Anderson says it is. "The value proposition is that content is so worthless that you have to pay to have it published, and you can't charge for it even then," he writes. Kevin Smith responds at Scholarly Communications @ Duke that "the value of scholarly work, for scholars, has never been based on the money it could earn, since they never saw a penny of that money and were, in fact, expected to pay for access to their own writings."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.